ID Sq-1 AC CVCL_4900 SY SQ-1; SQ1; Sq1 DR CLO; CLO_0050049 DR ArrayExpress; E-MTAB-2770 DR BioSample; SAMN03472088 DR BioSample; SAMN10988374 DR cancercelllines; CVCL_4900 DR Cell_Model_Passport; SIDM01767 DR CGH-DB; 192-1 DR CGH-DB; 9181-4 DR Cosmic; 889087 DR Cosmic; 946075 DR Cosmic; 1048222 DR Cosmic; 1066172 DR Cosmic; 1219090 DR Cosmic; 1239913 DR Cosmic; 2060523 DR DepMap; ACH-000553 DR GEO; GSM887647 DR GEO; GSM888739 DR IARC_TP53; 28446 DR IARC_TP53; 30172 DR LiGeA; CCLE_756 DR PharmacoDB; Sq1_1494_2019 DR Progenetix; CVCL_4900 DR RCB; RCB1905 DR TKG; TKG 0301 DR Wikidata; Q54955595 RX PubMed=9023415; RX PubMed=9416778; RX PubMed=9538136; RX PubMed=14581340; RX PubMed=15746151; RX PubMed=16105816; RX PubMed=17511773; RX PubMed=19472407; RX PubMed=20557307; RX PubMed=22460905; RX PubMed=24002593; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31978347; RX PubMed=38639832; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Population: Japanese. CC HLA typing: A*11:01,24:02; B*15:01,52:01; C*04:01,12:02 (PubMed=9023415). CC Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+2T>C (IVS4+2T>C); ClinVar=VCV000439316; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=20557307; DepMap=ACH-000553). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0.4%; Native American=0%; East Asian, North=81.37%; East Asian, South=17.66%; South Asian=0.56%; European, North=0%; European, South=0% (PubMed=30894373). ST Source(s): RCB=RCB1905; TKG=TKG 0301 ST Amelogenin: X,Y ST CSF1PO: 11,13 ST D13S317: 8 ST D16S539: 9,12 ST D5S818: 12,13 ST D7S820: 8,13 ST TH01: 7 ST TPOX: 8,11 ST vWA: 19 DI NCIt; C3493; Lung squamous cell carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 32 // RX PubMed=9023415; DOI=10.1006/cimm.1996.1062; RA Seki, Naoko RA Hoshino, Tomoaki RA Kikuchi, Megumi RA Hayashi, Akihiro RA Itoh, Kyogo RT "HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating RT lymphocytes of patients with non-small cell lung cancer."; RL Cell. Immunol. 175:101-110(1997). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x; PMCID=PMC11158680; RA Iwakawa, Reika RA Kohno, Takashi RA Enari, Masatoshi RA Kiyono, Tohru RA Yokota, Jun RT "Prevalence of human papillomavirus 16/18/33 infection and p53 RT mutation in lung adenocarcinoma."; RL Cancer Sci. 101:1891-1896(2010). // RX PubMed=16105816; DOI=10.1158/0008-5472.CAN-05-0331; RA Nagai, Yoshiaki RA Miyazawa, Hitoshi RA No_last_name, Huqun RA Tanaka, Tomoaki RA Udagawa, Kiyoshi RA Kato, Motoyasu RA Fukuyama, Shunichiro RA Yokote, Akemi RA Kobayashi, Kunihiko RA Kanazawa, Minoru RA Hagiwara, Koichi RT "Genetic heterogeneity of the epidermal growth factor receptor in RT non-small cell lung cancer cell lines revealed by a rapid and RT sensitive detection system, the peptide nucleic acid-locked nucleic RT acid PCR clamp."; RL Cancer Res. 65:7276-7282(2005). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=9416778; DOI=10.1016/S0024-3205(97)01010-2; RA Shoji, Masaru RA Kimura, Tokihisa RA Ota, Kozo RA Yamaji, Tohru RA Ishibashi, Miyuki RA Ohta, Masahiro RA Sasano, Hironobu RA Kawarabayasi, Yutaka RA Kimura, Noriko RA Funyu, Takeharu RA Mori, Takefumi RA Sahata, Takayuki RT "Genotype analysis of prepro-vasopressin signal peptide in RT vasopressin-producing and -non-producing lung tumors."; RL Life Sci. 61:2561-2566(1997). // RX PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x; PMCID=PMC11159702; RA Fukuyama, Takashi RA Ichiki, Yoshinobu RA Yamada, Sousuke RA Shigematsu, Yoshiki RA Baba, Tetsuro RA Nagata, Yoshika RA Mizukami, Makiko RA Sugaya, Masakazu RA Takenoyama, Mitsuhiro RA Hanagiri, Takeshi RA Sugio, Kenji RA Yasumoto, Kosei RT "Cytokine production of lung cancer cell lines: correlation between RT their production and the inflammatory/immunological responses both in RT vivo and in vitro."; RL Cancer Sci. 98:1048-1054(2007). // RX PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254; RA Nusinow, David Paul RA Szpyt, John RA Ghandi, Mahmoud RA Rose, Christopher M. RA McDonald, E. Robert 3rd RA Kalocsay, Marian RA Jane-Valbuena, Judit RA Gelfand, Ellen T. RA Schweppe, Devin Karl RA Jedrychowski, Mark P. RA Golji, Javad RA Porter, Dale A. RA Rejtar, Tomas RA Wang, Y. Karen RA Kryukov, Gregory V. RA Stegmeier, Frank RA Erickson, Brian K. RA Garraway, Levi Alexander RA Sellers, William Raj RA Gygi, Steven P. RT "Quantitative proteomics of the Cancer Cell Line Encyclopedia."; RL Cell 180:387-402.e16(2020). // RX PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210; RA Kasai, Fumio RA Fukushima, Makoto RA Miyagi, Yohei RA Nakamura, Yukio RT "Genetic diversity among the present Japanese population: evidence RT from genotyping of human cell lines established in Japan."; RL Hum. Cell 37:944-950(2024). // RX PubMed=15746151; DOI=10.1093/hmg/ddi092; RA Izumi, Hiroto RA Inoue, Jun RA Yokoi, Sana RA Hosoda, Hiroshi RA Shibata, Tatsuhiro RA Sunamori, Makoto RA Hirohashi, Setsuo RA Inazawa, Johji RA Imoto, Issei RT "Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in RT non-small cell lung cancers."; RL Hum. Mol. Genet. 14:997-1007(2005). // RX PubMed=19472407; DOI=10.1002/humu.21028; PMCID=PMC2900846; RA Blanco, Raquel RA Iwakawa, Reika RA Tang, Mo-Ying RA Kohno, Takashi RA Angulo, Barbara RA Pio, Ruben RA Montuenga, Luis M. RA Minna, John D. RA Yokota, Jun RA Sanchez-Cespedes, Montse RT "A gene-alteration profile of human lung cancer cell lines."; RL Hum. Mutat. 30:1199-1206(2009). // RX PubMed=14581340; RA Yokoi, Sana RA Yasui, Kohichiroh RA Iizasa, Toshihiko RA Imoto, Issei RA Fujisawa, Takehiko RA Inazawa, Johji RT "TERC identified as a probable target within the 3q26 amplicon that is RT detected frequently in non-small cell lung cancers."; RL Clin. Cancer Res. 9:4705-4713(2003). // RX PubMed=24002593; DOI=10.1038/bjc.2013.452; PMCID=PMC3776976; RA Wu, Di RA Pang, Yi RA Wilkerson, Matthew D. RA Wang, Die RA Hammerman, Peter S. RA Liu, Jun S. RT "Gene-expression data integration to squamous cell lung cancer RT subtypes reveals drug sensitivity."; RL Br. J. Cancer 109:1599-1608(2013). // RX PubMed=9538136; DOI=10.3892/ijo.12.5.1103; RA Takaki, Toshiyuki RA Hiraki, Akio RA Uenaka, Akiko RA Gomi, Shinya RA Itoh, Kyogo RA Udono, Heiichiro RA Shibuya, Akira RA Tsuji, Takao RA Sekiguchi, Sadayoshi RA Nakayama, Eiichi RT "Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 RT peptide recognized by cytotoxic T lymphocytes."; RL Int. J. Oncol. 12:1103-1109(1998). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). //